Osellidine is Used for Analgesia During Daytime Hysteroscopic Surgery

Starting soon

Conditions studied: Gynecological Day Surgery

In brief

While providing equivalent analgesic efficacy, oxelidine significantly reduces the risk of adverse reactions-including respiratory depression, gastrointestinal dysfunction, and cognitive impairment-and facilitates faster recovery of postoperative cognitive orientation. It thus aligns with the core goals of "precise analgesia and rapid recovery" in daytime anesthesia and has been widely adopted in clinical practice. Given the high heterogeneity among day surgery patients (e.g., age, comorbidities, and surgical complexity), real-world studies can better capture a drug's performance across diverse populations. Therefore, this study will use a prospective, observational, real-world design to systematically compare the effects of oxelidine and traditional analgesic regimens in patients undergoing daytime hysteroscopic surgery.

Key facts

Study ID

NCT07409311

Run by

Tongji Hospital

People needed

310

Starts

2026-02-10

Expected to finish

2028-02-01

Last updated by the study team

2026-02-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years.
• Scheduled to undergo gynecological hysteroscopic surgery under general anesthesia with laryngeal mask airway (LMA).
• Willing and able to provide written informed consent.

You may not qualify if…

• Incomplete medical records or data.
• Severe hepatic or renal dysfunction.
• Concurrent use of other potent analgesics (e.g., opioids, NSAIDs) or medications that may interfere with study outcomes.
• Participation in another clinical trial within the past 4 weeks

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.